KMT2A and acute myeloid leukemia: Two patients, 7 and 20, were identified to possess the chromosomal translocation t(6;11) (q27;q23) at the initial diagnosis of AML, which was predicted to lead to KMT2A/AFDN gene fusion (Fig. 1A).